HIGHLIGHTS
- who: Inki Moon and collaborators from the Department of Internal Medicine, Seoul National University Hospital, Seoul, KoreaDepartment of Clinical Medicine, Aalborg University, Aalborg, Denmark have published the research work: Clinical Medicine, in the Journal: (JOURNAL) of 31/Dec/2016
- what: Given that VHDs commonly co-exist in Asian patients with AF, the authors aimed to evaluate the effectiveness and safety of NOACs compared to those of warfarin, specifically in AF patients with EHRA type 2 VHDs, using a large real-world nationwide cohort of Korean individuals. In this study, the primary analysis was conducted in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.